Based on the results of recent randomized controlled trials, current international guidelines recommend the initiation of endovascular treatment within 6 hours of symptom onset for acute ischemic stroke. Endovascular treatment may be beneficial in selected patients beyond 6 hour time window. In particular, treatment response to endovascular therapy may be greatly influenced by pretreatment collateral status. The aim of this study is to evaluate whether MRI-based collateral imaging (the Fast Analysis SysTem for COLLaterals, 'FAST-COLL') is feasible and can predict the response to endovascular treatment in a wide range of patients with acute ischemic stroke .
Study Type
OBSERVATIONAL
Enrollment
120
Endovascular mechanical thrombectomy or endovascular delivery of thrombolytic agent
Samsung Medical Center, Sungkyunkwan University School of Medicine
Seoul, South Korea
RECRUITING90-days functional outcome
90-days modified Rankin Scale ≤ 2
Time frame: 90-days
Early neurologic improvement
An 8-point or more improvement on the NIH score when comparing the baseline score or a NIHSS score of 0-1, at 24 hours.
Time frame: 24 hours
Symptomatic hemorrhagic transformation
Occurrence of an increase in the National Institutes of Health Stroke Scale (NIHSS) score of 4 or more points in the setting of local or remote parenchymal hematoma.
Time frame: During initial admission
Successful recanalization
Defined as modified Thrombolysis in Cerebral Infarction (mTICI) ≥ 2b
Time frame: within 24 hours of symptom onset
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.